However, unlike BTN molecules, which are commonly expressed on both hematologic and solid tumors [41], CD1+ tumor cells mostly arise from myelomonocytic and B-cell lineages, and only a few solid tumors have been discovered to be CD1+ [42]. This evidence concerns the gene BTN1A1 and neoplasm.